Pancreatic Cancer Lawsuits For Januvia, Janumet, Byetta, Victoza

Written by lisaspitzer on . Posted in Drug Lawsuits

 Merck Supports MDL For Januvia, Janumet Lawsuits Over Pancreatic Cancer. Class Action Lawyer Network lawyers for Januvia, Janumet, Byetta and Victoza are filing pancreatic cancer lawsuits for diabetic victims of these medications.

Posted: 30 Apr 2013 08:25 AM PDT

Following a request filed by plaintiffs earlier this month to establish a federal MDL for all pancreatic cancer lawsuits involving the diabetes drugs Januvia, Janumet, Byetta and Victoza, Merck has indicated that it agrees cases involving their products should be included in any consolidated proceedings established.

In a response (PDF) filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) on April 29, Merck said that it agrees that all Januvia lawsuits and Janumet lawsuits filed in the federal court systems should be centralized before one judge for coordinated handling, as part of an MDL or multidistrict litigation.

Further, the drug maker indicates that it agrees that it is appropriate to include cases involving other diabetes drugs that are part of a class of medications, known as incretin mimetics, in the same MDL.

Merck manufactures Januvia (sitagliptin) and Janumet, which combines Januvia with the older diabetes drug metformin. The drug maker faces a growing number of lawsuits filed by former users of the medications who indicate that they developed pancreatic cancer from side effects of Januvia or Janumet, alleging that Merck failed to provide adequate warnings for consumers or the medical community.

A number of similar Byetta lawsuits and Victoza lawsuits have also been filed by former users of those competing diabetes drugs who have been diagnosed with pancreatic cancer. Many complaints also allege that the plaintiffs used a combination of the various different drugs over a number of years.

Diabetes Drug Pancreatic Cancer Risk

Incretin mimetics are a relatively new class of diabetes drug, which work by mimicking the incretin hormones that the body usually produces to naturally stimulate th release of insulin in response to a meal.

Byetta (exenatide) was the first member of this class approved by the FDA, introduced by Amylin Pharmaceuticals and Eli Lilly in 2005, as a twice daily injection. Januvia was introduced by Merck the following year as an oral medication, and a combination pill containing Januvia and the combination medication that includes metformin was introduced in 2007, under the brand name Janumet. Victoza (liraglutide) was introduced by Novo Nordisk in 2010 as a daily injection.

The medications are widely used among individuals with type 2 diabetes, generating billions in annual sales. Januvia and Janumet are among the best selling medications for the global pharmaceutical company Merck, with Janumet sales reaching over $1.3 billion in 2011 and Januvia sales hitting $919 million during the first quarter of 2012 alone. Byetta sales were reported at $710 million in 2010 and were expected to reach $1 billion by 2015. Likewise, Victoza sales were about $1 billion in 2011, and reached $748 million during the first half of 2012.

In recent months, concerns have emerged about the potential risk of pancreatic cancer from Byetta, Januvia, Janumet and Victoza. The medications have previously been linked to a risk of pancreatitis, which can lead to the development of pancreatic cancer.

Last month, the FDA launched an investigation into the potential incretin mimetics pancreatic cancer risk. The safety review was initiated after results of a recent study identified pre-cancerous cellular changes in pancreatic tissue taken from individuals treated with one of the drugs. European health officials have also launched a similar review.
Pancreatic Cancer Litigation Over Januvia, Janumet, Byetta and Victoza

As of the beginning of this month, at least 53 product liability lawsuits were pending in seven different U.S. District Courts alleging that Januvia, Janumet, Byetta and/or Victoza caused former users to develop pancreatic cancer. Lawyers investigating additional cases have also suggested that the number of complaints is expected to increase dramatically in the coming months.

On April 5, a group of plaintiffs filed a request to centralize the incretin mimetic pancreatic cancer litigation, indicating that all cases filed throughout the federal court system against Merck, Novo Nordisk (the manufacturer of Victoza) or Amylin Pharmaceuticals and Eli Lilly (the makers of Byetta) should be consolidated before U.S. District Judge Anthony Battaglia in the Southern District of California.

Such consolidation is designed to reduce duplicative discovery among a large number of cases, avoid conflicting rulings from different judges and to serve the convenience of the witnesses, parties and the courts. In the original motion, plaintiffs argued that there are sufficient overlapping common issues of fact and law to justify combining the cases against the different drug makers before one judge.

Responses from the manufacturer were due this week. As of the end of the day Monday, only Merck and Novo Nordisk had filed responses. Both drug makers indicated that they support the centralization of the litigation and agree that all cases involving pancreatic cancer from incretin mimetic diabetes drugs should be included in the same MDL. A response from Amylin and Eli Lilly was not yet available.

Both Merck and Novo Nordisk said the MDL should be limited to cases involving pancreatic cancer, as some users of the drugs have also reported severe pancreatitis and thyroid cancer as well. Both companies also agree that the Southern District of California is the best venue for the litigation.

The U.S. JPML is expected to schedule oral arguments on the motion at an upcoming hearing session on July 25 in Portland, Maine.

If you or a loved on has gotten pancreatic cancer from any of the mentioned medications call now for a  MDL lawyer.

Dangerous Drugs and Devices Alert, Get Justice Now, Class Action Lawyers

Written by lisaspitzer on . Posted in Drug Lawsuits, Medical Device Lawsuits

Every day we find new drugs and devices with new warnings. Class action lawyers are seeking justice for the injured. We are here to help you. If you have been injured by a dangerous drug or device, or what we call a " bad drug or device " call us for help.

  • AED Heart Device Lawsuits,
  • Actos,
  • Benzene Exposure.,
  • Car Seat Failure,
  • DePuy Hip Replacement Problems,
  • Fosamax Lawsuits,
  • Mirena IUD for Uterine perforation,
  • GranuFlo, and NaturaLyte,
  • Carbon Dioxide poisoning,
  • Medtronic Infuse Bone Graft, Spinal Medical Device
  • Sketcher Sneakers,
  • Mesothelioma,
  • Insurance Fraud claims,
  • QUi Tam,
  • NuvaRing,
  • Pradaxa,
  • Transvaginal Surgical Mesh Lawsuit,
  • Pelvic Mesh lawyers,
  • Bladder Sling lawyer,
  • Tramatic Brain Injury lawyer,
  • Stryker Rejuvinate Hip Replacement lawyer, ABG II Recalls
  • YAZ class action,
  • Yasmin,
  • Meningitis from Steroid Injections,




Fosamax Helpline, Fosamax Lawyers, Fosamax Injury Help

Written by lisaspitzer on . Posted in Drug Lawsuits

A Fosamax Helpline has been launched by the Fosamax Class action lawyers filing lawsuits in the Fosamaz MDL.The Fosamax Helpline wants to locate all women injured by Fosamax and help them file their Fosamx lawsuit and obtain justice. We do not want any women to be left out. The statute of limitations is running close in many states.

Fosamax lawsuit Filings Are Increasing
According to recent court documents, more than 2,200 Fosamax lawsuits are pending in court by  victims who have suffered femur fractures and  jaw problems  from taking Fosamax. Fosamax is  manufactured by Merck.and was approved by the FDA in 1995. Fosamax is for the of l osteoporosis  usually experienced by post menapausel women. Currently the Fosamax lawsuits have been consolidated  in a Multi District Litigation before Judge Carol Higbee in the Superior Court for Atlantic County, New Jersey.

The claim of the lawsuits is for the resulting  atypical femoral fractures associated with bisphosphonate or Fosamax in women for the prevention of Osteoporosis and medical condition that results in decreased bone density and fractures. Fosamx in fact was actually shown to cause the fractures it was to prevent.

The Fosamx Helpline is reaching out thru and nationwide infromation launch to all women who have taken Fosamax with resulting femur fracture. New medical documentation shows that  In addition to Fosamax femur fractures, other potential side effects include jawbone damage, ulcers in the stomach and esophagus, eye inflammation, and severe, incapacitating muscle, bone, and joint pain.

Class Action Lawyer Network lawyers are currently accepting Fosamax cases.




Mesothelioma Lawyers, Lung Cancer From Asbestos

Written by lisaspitzer on . Posted in Alabama Multidistrict Litigation Lawyers, Arizona Multidistrict Litigation Lawyers, Arkansas Multidistrict Litigation Lawyers, Asbestos, California Multidistrict Litigation Lawyers, Class MDL Class Action News, Colorado Multidistrict Litigation Lawyers, Connecticut Multidistrict Litigation Lawyers, Delaware Multidistrict Litigation Lawyers, Drug Lawsuits, Florida Multidistrict Litigation Lawyers, Georgia Multidistrict Litigation Lawyers, Idaho Multidistrict Litigation Lawyers, Illinois Multidistrict Litigation Lawyers, Indiana Multidistrict Litigation Lawyers, Iowa Multidistrict Litigation Lawyers, Kansas Multidistrict Litigation Lawyers, Kentucky Multidistrict Litigation Lawyers, Louisiana Multidistrict Litigation Lawyers, Maine Multidistrict Litigation Lawyers, Maryland Multidistrict Litigation Lawyers, Massachusetts Multidistrict Litigation Lawyers, Michigan Multidistrict Litigation Lawyers, Minnesota Multidistrict Litigation Lawyers, Mississippi Multidistrict Litigation Lawyers, Missouri Multidistrict Litigation Lawyers, Montana Multidistrict Litigation Lawyers, Nebraska Multidistrict Litigation Lawyers, New Jersey Multidistrict Litigation Lawyers, New Mexico Multidistrict Litigation Lawyers, New York Multidistrict Litigation Lawyers, North Carolina Multidistrict Litigation Lawyers, North Dakota Multidistrict Litigation Lawyers, Ohio Multidistrict Litigation Lawyers, Oklahoma Multidistrict Litigation Lawyers, Oregon Multidistrict Litigation Lawyers, Pennsylvania Multidistrict Litigation Lawyers, Rhode Island Multidistrict Litigation Lawyers, South Carolina Multidistrict Litigation Lawyers, South Dakota Multidistrict Litigation Lawyers, Tennessee Multidistrict Litigation Lawyers, Texas Multidistrict Litigation Lawyers, Toxic Substances, Utah Multidistrict Litigation Lawyers, Vermont Multidistrict Litigation Lawyers, Virginia Multidistrict Litigation Lawyers, Washington DC Multidistrict Litigation Lawyers, Washington Multidistrict Litigation Lawyers, West Virginia Multidistrict Litigation Lawyers, Wisconsin Multidistrict Litigation Lawyers, Wyoming Multidistrict Litigation Lawyers

Class Action Lawyer Network has launched a mesothelioma helpline for victims of asbestos related cancer and their families, The helpline is run by a medical social worker who will offer support and connect you to a mesothelioma lawyer.

What is Asbestos?
Asbestos is a group of minerals that occur naturally in the environment and asbestos has been  used in many industries. As a worker If asbestos fibers are breathed in,  you can get asbestosis or  a scarring of the lung tissue resulting in mesothelioma and lung cancer.

There are two  types of asbestos:

  • chrysotile asbestos
  • amphibole asbestos

Our mesothelioma lawyers  are here for  Asbestos victims and their families. Our Mesothelioma helpline  Asbestos attorneys and medical social worker understand how difficut it is the watch your loved one deteriorate from this disease and feel helpless.

This dangerous lung cancer causing substance can be found in many work environments. if your loved one has worked in an asbestos work environment and has fallen vitim to mesotelioma we can help.

Workers inhaling large amounts of asbestos can get:

  •     Asbestosis
  •     scarring of the lungs
  •     Pleural plaques
  •     Pleural effusions
  •     fluid buildup between lungs and chest cavity
  •     Pleural thickening

Workers with a high risk of developing mesothelioma were exposed to asbestos at work or through large quantities of environmental contact.

Millions of workers since the 1940s have been exposed to asbestos. Those at risk for asbestos-related illnesses worked in the following industries:

  •     Shipbuilding
  •     Mining and milling
  •     Maritime industry
  •     steel mills
  •     Automobile
  •     Asbestos textile manufacturing
  •     Construction and building
  •     Drywall or asbestos removal
  •     First responders to burning buildings or buildings with asbestos exposed the fumes


Symptoms of Asbestos related lung cancer

  •     Breathlessness or shortness of breath
  •     A cough that won't go away
  •     Coughing up blood
  •     Wheezing or hoarseness
  •     Fatigue or anemia
  •     Trouble swallowing
  •     Pain or tightening in the chest
  •     Swelling of the neck or face
  •     Weight loss
  •     Loss of appetite

Asbestos and Asbestosis

 For people with severe exposure to asbestos, three of the primary causes of death are: scarring of the lungs,asbestosis, lung cancer and  mesothelioma.
While mesothelioma is the most well known illness caused by exposure to asbestos, it is not the only one. Another significant illness caused by asbestos is asbestosis.

If you or a loved one has toxic exposure due to asbestos resulting in mesothelioma contact our mesothelipoma helpline today.


Actos Lawyers Filing Actos Lawsuits, Actos Linked to Bladder Cancer

Written by Class Action Lawyer on . Posted in Actos Lawsuit Lawyers, Drug Lawsuits, Multidistrict Lawsuit News

Actos Linked To Bladder Cancer

 Actos has been linked to bladder cancer with use of over 2 years.

Seniors and minority groups are usual victims of Actos. Actos is a drug used for Type II, adult onset, diabetis.

Thousands of Actos Bladder Cancer  Lawsuits Are  Anticipated

Actos Timeline Gives The Actos Lawsuit Statute  Starting Date

Jun 10, 2011: Use of Actos is banned in France and Germany. The French Medicines Agency removed the drug from the market after analyzing the data collected from 2006 to 2009.

Jun. 15, 2011: FDA announces “that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” Warning labels are to be updated subsequently. The agency warns healthcare professionals against prescribing Actos in patients who have bladder cancer or have a history of bladder cancer.

Jul. 2011: The EMA states that Actos should include the risk of bladder cancer on its warning label, according to Reuters.

Aug.  4, 2011: – The FDA approves the label change for product containing pioglitazone (marketed as Actos, Actoplus Met, and Duetact) previously announced on June 15, 2011.

Actos Lawsuit  MDL Consolidation

Actos pillsThousands of Actos lawsuits are anticipated in the multidistrict litigation (MDL) filing ordered by Judge Rebecca Doherty. The honorable Judge Doherty stated in a recent order that "the number of claims which will be included could reach into the thousands," in reference to the new Actos lawsuit MDL she ordered be created. Judge Doherty is not presiding over an Actos class action lawsuit.
The MDL was created so that Judge Doherty will have one common point of reference for the thousands of cases expected. This specific MDL lets all of the affected Actos users work together so they are all essentially covered under one lawsuit (similar to a class action.) Unlike an Actos class action lawsuit, where the payout per participant may be small, an award from the Actos MDL could amount to tens or hundreds of thousands of dollars per litigant. It could even be in the million dollar range if the an Actos user's death was tied back to taking Actos and developing bladder cancer or another severe adverse side effect of Actos.

Get An Actos Lawyer

An experienced Actos attorney will be able to help determine what financial awards may be possible based on the severity of the injury and required treatment due to taking Actos.

Actos Bladder Cancer Symptoms

It's important that Actos users know what to look out for if they have taken Actos for more than one year which allegedly increases the risk of bladder cancer by at least 40%. Symptoms of bladder cancer include tumors which could cause blood in the urine, painful or frequent urination, or straining during urination. In addition, other common symptoms of bladder cancer include fatigue, incontinence, weight loss and bone pain or tenderness. If you are experiencing these symptoms you should see a doctor immediately so bladder cancer or tumors can be ruled out.

Speak To An Actos Bladder Cancer Lawyer and See Your Doctor Right Away

If you are experiencing these symptoms and are diagnosed with bladder cancer or tumors it may be a good idea to speak with an attorney to see if you are able to file an Actos lawsuit under the new MDL.


Consumer Advocates Push to reopen Yaz Blood Clot Debate, Yaz lawyers Accepting Victims of Yaz

Written by Class Action Lawyer on . Posted in Drug Lawsuits

Consumer Advocates Call for Reopening of Yaz Blood Clot Risk Debate

Consumer Advocates wants the FDA to reopen its debate about the risk of bllod clots for Yaz and the coagulum dangers of similar birth-control pills, including Yasmin. Class Action Network lawyers are accepting Yaz clients with blood clot complications form yaz.

Many believe an extended discussion about these drospirenone-based contraceptives would be in the best interests of the millions of American women who rely on this drug for  birth control. Yaz is just one of many dangerous drugs and medical device harming women like Topamax, Fosamax, Vaginal Mesh, Breast Implants, Mirena IUD and others.

Interest in such a dialogue is particularly keen just now among individuals, organizations and policymakers alarmed about the right of women to access contraceptives. The debate over contraception has been quite a political issue lately.

One such group calling for more debate is the Project on Government Oversight (POGO). The organization is asking the  FDA vote again on whether the Yaz blood clot risk outweighs its benefits. An FDA advisory panel in December voted by a slim margin of just four votes out of 26 total cast to recommend the agency keep Yaz and its imitators on the market, despite the concerns over complications and blood clots   POGO identified four voters on that advisory panel who had financial relationships or business connections with the makers of the birth-control pills at issue. It is believed this may have made a difference in the votes.

Critics of that vote  assert that the FDA needs to ensure a fair and honest debate about the Yaz blood clot risk by removing from the discussion those participants who have conflicts-of-interest. This was definately a conflict of interest.

The risks cited by medical studies and by the FDA with regard to drospirenone-based birth-control pills include  strokes and life threatening complications.

Class Action Lawyer Network Yaz lawyers are accepting clients injured by the birth control pill Yaz.

Actos for causing Bladder Cancer, First Hearing being held

Written by Class Action Lawyer on . Posted in Drug Lawsuits

Actos has been shown to cause bladder cancer. First hearing being held for Actos and Class Action Lawyer Nework Actos Lawyers are accepting new cases.


(AP)  NEW ORLEANS — A federal judge in Louisiana has scheduled an initial court hearing for a batch of lawsuits that claim Takeda Pharmaceuticals' top-selling diabetes drug, Actos, carries an increased risk of bladder cancer.

In an order issued Monday, U.S. District Judge Rebecca Doherty said she plans to appoint lead attorneys for the consolidated cases after the March 22 status conference in her Lafayette, La., courtroom.

In December, the U.S. Judicial Panel on Multidistrict Litigation assigned Doherty to preside over dozens of lawsuits against Actos maker Takeda Pharmaceuticals America Inc., which is based in Deerfield, Ill. Plaintiffs' attorneys expect to file several thousand claims against Takeda and its related companies on behalf of people who used the drug.

Takeda's Japanese parent company, Takeda Pharmaceuticals Co. Ltd., halted sales of Actos in Germany and France last year. The U.S. Food and Drug Administration issued a warning about the drug's possible cancer risks in 2010 but allowed sales to continue.

After the FDA approved Actos in 1999, Takeda co-promoted the drug in the U.S. with Eli Lilly & Co. Takeda took over responsibility for the drug's marketing when the agreement between the company ended in 2006, attorneys for the companies said in court papers.

An FDA spokeswoman says information about a possible risk of bladder cancer associated with the use of Actos has been on its label since the drug was approved for treating Type 2 diabetes in 1999.

Takeda released a statement on Tuesday saying that it works hard to evaluate any potential risks associated with its products.

"Takeda is confident in the therapeutic benefits of Actos and its importance as a treatment for type 2 diabetes. As a science and evidence-based company, Takeda firmly stands behind the substantial data available confirming the positive risk/benefit profile of Actos, which includes twelve years of clinical and patient experience with the product," the statement said.

The first lawsuit linking Actos to bladder cancer was filed against Takeda and Eli Lillly in July 2011, according to the companies' lawyers.

Paul Pennock of Weitz & Luxenberg, a New York firm that represents dozens of people with Actos-related claims, said Judge Doherty is now handling roughly 150 of these suits. Thousands more could have federal claims filed in or transferred to Lafayette by the end of the year, he said.

"People should not run the risk of getting bladder cancer from treating their diabetes given the many other excellent therapies available," Pennock said.

Thousands of other claims involving Actos are expected to be heard in California and Illinois state courts.

The lawsuits claim researchers have found that people who take Actos for more than a year are at increased risk of developing bladder cancer. The suits also accuse Takeda of concealing their knowledge of the cancer risks and failing to adequately warn consumer and health care providers.

Actos sales in the U.S. fell by roughly 3 percent last year, but the drug remained the best-selling Type 2 diabetes drug on the market, according to the health care information firm IMS Health. The firm says Actos accounted for $3.4 billion in sales in 2011, or nearly 84 percent of sales among drugs in the same class.

Class action layers of Class Action lawyer Network are accepting cases of bladder cancer form Actos. Multi District litgation filed

Darvocet lawyers, Multi District litigation Lawyers

Written by Class Action Lawyer on . Posted in Drug Lawsuits

In November, 2010, the FDA announced that it was pulling off the U.S. market the prescription painkillers, Darvon and Darvocet, which combines Darvon with the aspirin substitute acetaminophen, because of scientific evidence the drugs can damage the heart, even at recommended doses, or cause fatal cardiac abnormalities.  Studies have shown that the ingredients contained in Darvocet and Darvon have been linked to various forms of severe side effects. Reportedly, these side-effects include: heart arrhythmia, heart attack, suicide, accidental overdose and death.

Serious side effects include:

  •     an allergic reaction
  •     slow or weak breathing; difficulty breathing
  •     cold, clammy skin
  •     severe dizziness
  •     severe weakness
  •     loss of consciousness
  •     yellow skin or eyes
  •     extreme fatigue
  •     bleeding or bruising, which is unusual

Propoxyphene can cause changes to the electrical activity of the cardiovascular system including:

  •     ventricular fibrillation: where the heart can stop pumping blood, usually resulting in sudden cardiac death
  •     atrial fibrillation: an abnormal heart rhythm that could lead to stroke or heart attack from a blood clot

 Other Side Effects of Darvon and Darvocet

  •     heart attack
  •     stroke
  •     death
  •     numerous cardiac disorders (arrhythmia, bradycardia, tachycardia, heart attack)
  •     irregular heart beat
  •     chest pain
  •     shortness of breath
  •     excessive sweating
  •     dizziness
  •     fatigue
  •     nausea and vomiting
  •     loss of consciousness
  •     decrease in mental abilities

Class Action lawyer Network Attorneys and Multi District litigation lawyers are accepting clients injured by or with loved ones killed by reactions and complications from Darvocet.

list of Dangerous Drugs and medical devices For Class Action lawsuits

Written by Class Action Lawyer on . Posted in Drug Lawsuits

alert Dangerous Drugs

    Darvon & Darvocet
    Definity & Optison

    Medtronic Infuse Bone Graft

    Simvastatin + Amiodarone

alert Defective Medical Devices

    Breast Implants
    DePuy ASR
    DePuy Pinnacle
    Ikaria INOmax DS Drug Delivery System

    Pain Pump
    Riata Defibrillator Leads
    Vaginal Mesh
    Wright Profemur Z

alert Unsafe Consumer Products

    Denture Cream
    Window Shade


Boniva, Jaw Complications, Hip Fractures, Fosamax Lawyers

Written by Class Action Lawyer on . Posted in Drug Lawsuits


Boniva is a drug  manufactured by GlaxoSmithKline. Boniva has been linked to a serious bone disease called Osteonecrosis of the Jaw (ONJ), osteomyelitis, or dead jaw. Boniva is also linked to causing  femur and hip fractures.

 Class Action Lawyer Network Attorneys for Bonva are accepting Boniva induced ONJ, osteomyelitis, dead jaw, femur fracture and hip fracture claims in all thru-out the United States.If you have taken  Boniva and suffered one of the aforementioned side effects, you should contact Class Action Lawyer Network. Class Action Lawyer Network has a dangerous drug helpline to assit you with injuries from all dangerous drugs, medical devices and surgical implants.
Some Information about Boniva

Boniva is part of a class of drugs called bisphosphonates. Actonel, Aredia, Boniva, Fosamax, Reclast and Zometa are part of this class. These drugs prevent and treat osteoporosis. These drugs are also used at an earlier age in over 36 million women due to the increased risks that come along with hormone replacement therapy. Because women use these drugs at an earlier age and for longer time spans, they are more prone to developing Osteonecrosis of the Jaw (ONJ). Signs and symptoms of ONJ include pain, loosening of the teeth, swelling or infection of the gums, poor healing of gums, drainage and exposed gums. Since 2001, there have been over 2,400 reported cases of jaw bone decay and death or ONJ after the use of Fosamax (also a bisphosphonates). The pain from this bone disease is so debilitating that there have been over 120 patients who have become bedridden or who now rely on wheelchairs, walkers or crutches. The side effects of these medications are severe. If you believe you are having side efffects from Boniva and related medications see your physician immediately  to consider an alternate medication.
What are the side effects of Boniva?

  •     Osteonecrosis of the Jaw
  •     Dead Jaw
  •     Osteomyelitis
  •     Pain
  •     Swelling or infection of the gums
  •     Loosening of the teeth
  •     Poor healing of the gums
  •     Numbness or a feeling of heaviness in the jaw
  •     Drainage
  •     Exposed bone
  •     Hip Fractures
  •     Femur Fractures

If you have complications from Boniva you may have a lawsuit for your injury

Class Action lawyer Network Attorneys are reviewing cases for  Boniva.  Cases are being reviewed for injury in all 50 states.  Class Action lawyer Network will connect you with an experienced Boniva Attorney.


Switch to Desktop Version